Skip to main content

Table 4 Intraprocedural characteristics (n = 780)

From: Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants

  Group A
Bridging
(n = 111)
Group B
VKA
(n = 318)
Group C
DOAC
(n = 351)
p-value
A-B
p-value
A-C
p-value
B-C
Procedural time (min) 241.5 ± 94.6 225.4 ± 83.4 185.1 ± 74.7 0.092 < 0.001 < 0.001
Heparin dosage (IU) 9176.0 ± 3774.1 7994.8 ± 3120.3 10457.3 ± 4293.5 0.003 0.005 < 0.001
Heparin dosage (IU/h) 2497.7 ± 1183.4 2335.1 ± 1091.3 3666.1 ± 1554.8 0.187 < 0.001 < 0.001
Heparin dosage (IU/h/kg) 29.4 ± 14.7 27.8 ± 19.9 44.00 ± 18.8 0.33 < 0.001 < 0.001
Mean ACT (seconds) 337.3 ± 64.3 335.6 ± 45.8 315.7 ± 44.1 0.803 0.001 < 0.001
Max ACT (seconds) 363.7 ± 48.5 383.8 ± 30.4 370.7 ± 32.8 < 0.001 0.163 < 0.001
Time to ACT> 300 (seconds) 70.1 ± 66.7 36.6 ± 34.5 26.8 ± 17.2 < 0.001 < 0.001 < 0.001
  1. Legend: values are means with standard deviations; ACT activated clotting time, Bridging interrupted vitamin-K-antagonist, DOAC uninterrupted non-vitamin-K-anticoagulants, h hour, IU international units, kg kilogram, max maximal, min minutes